JASPER THERAPEUTICS, INC. Increase (Decrease) in Prepaid Expenses, Other
JASPER THERAPEUTICS, INC. (JSPR) reported Increase (Decrease) in Prepaid Expenses, Other of -$1.47 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2023-11-09
- JASPER THERAPEUTICS, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2023-09-30 was -$1.40M.
- JASPER THERAPEUTICS, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2023-06-30 was -$353.00K.
- JASPER THERAPEUTICS, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2023-03-31 was $290.00K, a 7.81% increase year-over-year.
- JASPER THERAPEUTICS, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2022-12-31 was $1.36M, a 29.54% decline year-over-year.
- JASPER THERAPEUTICS, INC. increase (decrease) in prepaid expenses, other for fiscal 2022 was -$312.00K, a 114.10% decline from fiscal 2021.
- JASPER THERAPEUTICS, INC. increase (decrease) in prepaid expenses, other for fiscal 2021 was $2.21M.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 3 month | Increase (Decrease) in Prepaid Expenses, Other 6 month | Increase (Decrease) in Prepaid Expenses, Other 9 month | Increase (Decrease) in Prepaid Expenses, Other 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$1.76M derived: sum of 2 quarters · filed 2023-11-09 | -$1.47M 10-Q · filed 2023-11-09 | -$110.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | -$353.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$63.00K 10-Q · filed 2023-08-11 | $1.29M derived: sum of 3 quarters · filed 2023-08-11 | $283.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-03-31 | $290.00K 10-Q · filed 2023-05-12 | $1.65M derived: sum of 2 quarters · filed 2023-05-12 | $636.00K derived: sum of 3 quarters · filed 2023-11-09 | -$291.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-12-31 | $1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $346.00K derived: sum of 2 quarters · filed 2023-11-09 | -$581.00K derived: sum of 3 quarters · filed 2023-11-09 | -$312.00K 10-K · filed 2023-03-08 |
| 2022-09-30 | -$1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$1.94M derived: sum of 2 quarters · filed 2023-11-09 | -$1.67M 10-Q · filed 2023-11-09 | $257.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$927.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$658.00K 10-Q · filed 2023-08-11 | $1.27M derived: sum of 3 quarters · filed 2023-08-11 | |
| 2022-03-31 | $269.00K 10-Q · filed 2023-05-12 | $2.19M derived: sum of 2 quarters · filed 2023-05-12 | ||
| 2021-12-31 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $2.21M 10-K · filed 2023-03-08 | ||
| 2021-09-30 | $286.00K 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |